Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $73.7600 (3.15%) ($71.4800 - $73.7600) on Fri. Feb. 17, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.47% (three month average) | RSI | 68 | Latest Price | $73.7600(3.15%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 1% a day on average for past five trading days. | Weekly Trend | LGND advances 1.5% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IWC(53%) IWM(53%) IWN(53%) IWO(53%) XBI(52%) | Factors Impacting LGND price | LGND will decline at least -1.235% in a week (0% probabilities). VIXM(-25%) SHY(-22%) GLD(-14%) BWX(-10%) BNDX(-10%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.235% (StdDev 2.47%) | Hourly BBV | 2.1 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $72.19(2.17%) | 10 Day Moving Average | $71.69(2.89%) | 20 Day Moving Average | $71.37(3.35%) | To recent high | -6% | To recent low | 19% | Market Cap | $1.185b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |